Your browser does not support JavaScript capabilities, which maybe required to display this page properly.


PDF FormatRequires Adobe Acrobat Reader

Table 7.6c

Immunosuppression Use for Induction by Steroid Use at Discharge, 2004 to 2008

Recipients with Pancreas After Kidney (PAK) Transplants

  No Steroids Used for Maintenance Steroids Used for Maintenance
N % N %
Functioning Graft with Immunosuppression Info at Discharge 460 100.0% 889 100.0%
Induction Drugs        
Atgam/NRATG/NRATS 7 1.5% 14 1.6%
OKT3 1 0.2% 1 0.1%
Thymoglobulin 273 59.3% 492 55.3%
Zenapax 9 2.0% 52 5.8%
Simulect 12 2.6% 58 6.5%
Campath 129 28.0% 96 10.8%
Rituximab     4 0.4%
No Induction Drug Reported 74 16.1% 201 22.6%


Source: OPTN/SRTR Data as of May 4, 2009.

Includes patients with a functioning graft at discharge.

Steroids used for induction are not counted.

Individual induction drug percentages will not necessarily add up to 100 percent, as patients may be prescribed more than one induction drug.



PDF FormatRequires Adobe Acrobat Reader